Futura Medical plc (FAMDF)

Market Cap	8.69M -80.8%
Revenue (ttm)	10.86M -5.6%
Net Income	-8.62M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,000
Average Volume	44,079
Open	0.0170
Previous Close	0.0120
Day's Range	0.0170 - 0.0170
52-Week Range	0.0013 - 0.2000
Beta	0.21
RSI	49.44
Earnings Date	Apr 10, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: OTCMKTS
• Ticker Symbol: FAMDF

Financial Performance

Financial numbers in GBP